Spinal Muscular Atrophy Therapies: ICER Grounds the Price to Value Conversation in Facts.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 31778615.
- Also identified by DOI 10.18553/jmcp.2019.25.12.1306 and PMC identifier 10403758.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
No funding supported the writing of this commentary. The authors are employed by Prime Therapeutics, a pharmacy benefits management company.
Medical subject headings
- Muscular Atrophy, Spinal